In the pathway leading to antibody production there are two points at which CD4 ⍣ T h cells need to be recruited. The first of these is priming of T cells by their interaction with dendritic cells (DC) bearing antigen presented on MHC class II molecules and the second is the collaborative interaction of these primed T cells with B cells presenting the same antigen. We have previously shown that the configuration of T and B cell determinants within synthetic peptide immunogens can greatly influence the amount of immunogen required to produce an antibody response. Here we investigate whether the difference in potency of different immunogens is related to their ability to be presented by either DC or B cells. We show that determinants in a branched configuration, which are the most efficient at eliciting antibody in vivo, are presented to T cell clones by splenic CD8 -DC 10-fold more efficiently than the corresponding determinants in a tandem linear arrangement. B cells also showed preferential presentation of branched immunogens to one T cell clone but in contrast to DC, not to a second T cell clone, indicating differences between the two antigen-presenting cell types. We also show that branched immunogens have a greater stability in serum compared to linear peptides, which may further enhance the differences in their in vivo potency.
Introduction
Following administration of a synthetic peptide, a plethora of eliciting antibody when compared to the same determinants assembled in a linear conformation and the copy number of events must occur in order to generate an antibody response. These include the uptake of antigen by an antigen-presenting the B cell determinant was also found to affect the level of antibody produced; branched synthetic peptide constructs cell (APC) and the activation of naive T cells, functions which are carried out most efficiently by dendritic cells (DC) .
which contained a T h cell determinant and two B cell determinants elicited higher and more consistent antibody titers than Activated T cells must then engage a B cell to deliver the appropriate signals that initiate B cell differentiation and the equivalent synthetic peptide constructs containing a single B cell determinant. subsequent antibody production.
A number of reports (1-5) indicate that the orientation of B The contribution of these physical attributes of a synthetic peptide construct to immunogenicity is often a reflection of and T cell epitopes with respect to each other within a synthetic peptide construct affects the ensuing antibody the accessibility of amino acids within the epitope that are important binding sites for proteases, antibodies and other response. Using synthetic peptide-based designer immunogens we have shown that the geometry of assembly of B cell receptors encountered throughout the processing pathway. Clearly, such processing and binding events are sequence determinants and T h cell determinants is also an important factor in the induction of specific antibody (6). Branched dependent; however, at another level, the valency, geometry and physical characteristics of an immunogen are also importsynthetic peptide constructs were found to be superior in ant. The ability of APC to capture antigen has a major affect on the levels of expression of antigenic determinants on MHC class II molecules (reviewed in 7) and evidence is emerging that different APC display unique combinations of mechanisms for antigen uptake (reviewed in 7,8). These properties must influence downstream mechanisms and even the type of APC that becomes involved in antigen uptake and presentation.
Investigations into the effect that different APC have on the presentation of antigen revealed that the type of APC and also the subtype of APC involved can affect T cell activation. Recent studies using murine DC have revealed that subtypes of freshly isolated splenic DC distinguished by the presence or absence of the cell-surface marker CD8α (9) have very different effects on T cells (10,11). CD8 ϩ DC are much less efficient than CD8 -DC at stimulating proliferation of naive allogeneic CD4 ϩ T cells, the result of a regulatory mechanism mediated by the CD8 ϩ DC which results in rapid Fas-mediated cell death of the CD4 ϩ T cell population (10). CD8 ϩ DC can also modulate the proliferation of CD8 ϩ T cells by regulating IL-2 production, which in turn limits T cell expansion (11).
Once DC have activated the appropriate T cell subset, B cells are also required to process and present the same antigen to the activated T cell to receive the necessary signals to induce antibody production. Antigen is captured by the surface-bound Ig on the extracellular face of the B cell. is thought to be not only a result of increased endocytosis of the BCR but also due to post-endocytic sorting events that target the BCR-antigen complex to MHC class II loading compartments (7,12). Although naive B cells are capable of pinocytosis, the kinetics of this process are slow and this is acids. Peptides were purified using reverse-phase FPLC and characterized by analytical HPLC and amino acid analysis. not a major mechanism for antigen uptake. Studies in B cell systems have, however, shown that empty class II MHC A schematic of the peptide constructs is shown in Fig. 1 . Peptide 306-328 has been shown to be capable of eliciting molecules are capable of recycling through early endosomes to be re-expressed on the cell surface (13) (14) (15) (16) , and this antibody without being coupled to a carrier protein (19) , and therefore contains both T cell and B cell epitopes. This pathway is accessible to and often preferred by exogenous antigen (17) . Some antigens have been shown to be independpeptide is derived from the influenza virus haemagglutinin and contains a T cell determinant PKYVKQNTLKLA (20) and ent of HLA-DM and invariant chain for peptide loading (13, 18) which adds support to a mechanism of recycling class II an overlapping B cell determinant TLKLATG (21, 22) . The T cell determinant ALNNRFQIKGVELKS is derived from a distal MHC as an alternate presentation pathway in naive B cells.
In this study we have used the CD8 -DC subpopulation, part of the haemagglutinin molecule (23) of influenza virus. freshly isolated from splenocytes, together with purified Influenza virus splenic B cells to present synthetic peptide antigens to T cells in experiments aimed at increasing our understanding
The virus designated Mem71 is a reassortant containing the hemagglutinin of type A influenza strain A/Memphis/1/71 of the mechanisms responsible for the differences in immunogenicity exhibited by chemically similar but geometrically (subtype H3) and the neuraminidase of A/Bellamy/42 (N1). different peptide constructs.
Cell lines
All cell lines were maintained by passage in RPMI 1640 Methods supplemented with 10% heat-inactivated (56°C, 30 min) FCS, 2 mM glutamine, 2 mM sodium pyruvate, 0.1 mM 2-mercaptoSynthetic peptides ethanol, 30 µg/ml gentamicin, 100 IU/ml penicillin and 100 µg/ml streptomycin, with or without exogenous cytokines, in The synthesis and purification of the peptide constructs used in this study have been described elsewhere (6). Briefly, six-well culture plates (Nunc, Roskilde, Denmark). A20 cells are derived from a B cell lymphoma cell line expressing H-2 d all peptides were synthesized using solid-phase peptide chemistry using the free-acid forms of Fmoc-derivitized amino class II MHC (24) and do not require supplements. The cell line HT2 (25) is cytokine-dependent and requires the presence FACS analysis of IL-2, which was provided in the form of supernatant from FACS analysis was carried out using a FACSort (Becton concanavalin A-stimulated spleen cells.
Dickinson, San Jose, CA) flow cytometer and data were analyzed using CellQuest software. Each sample was col-T cell clones lected ungated with 10,000 events per sample. Isolated B cells were treated with a fluoresceinated sheep anti-mouse The derivation, preparation and maintenance of T cell clones Ig antibody (Dako, Copenhagen, Denmark) to detect surface-12V1 and 4.51 are described elsewhere (20, 23) . Briefly, T bound Ig. Cells were incubated on ice with a 1/50 dilution of the cell clones were maintained by passage every 5 days with antibody in PBS. Labeled cells were compared to untreated B influenza virus Mem71 and γ-irradiated BALB/c spleen cells cells and also to untreated splenocyte samples to enable the as a source of APC, alternated with 7 days in medium lymphocyte region to be gated. All cells were then fixed in supplemented with IL-2.
1% T cell proliferation assays using fixed A20 cells as APC Cells were fixed using the protocol described by Harding B cell isolation (28) . Briefly cells were resuspended at 5ϫ10 6 cells/ml in a Mice were killed by cervical dislocation and their spleens 1:1 ratio of RPMI 1640 (supplemented with 30 µg/ml gentamremoved. Single-cell suspensions were prepared by passage icin, 100 IU/ml penicillin and 100 µg/ml streptomycin) and a through a wire sieve and erythrocytes removed by treatment 2% w/v solution of paraformaldehyde in PBS for 5 min at room with ammonium Tris-chloride buffer (26) . Cells, at a concentratemperature. Cells were then washed once with RPMI medium tion of 10 8 /ml, were then loaded onto a 20 or 30 ml Sephadex and resuspended in a solution (0.4 M) of lysine in water which G-10 column that had been equilibrated at 37°C in RPMI had been diluted in an equal volume of RPMI prior to use to 1640 supplemented with 5% heat-inactivated (56°C, 30 min)
give a final wash solution concentration of 0.2 M. Cells were FCS, 10 mM HEPES buffer, 30 µg/ml gentamicin, 100 IU/ml incubated with the lysine wash solution for 25-30 min at room penicillin and 100 µg/ml streptomycin (RF5 ϩ ). This protocol temperature, then washed 3 times with RPMI and diluted to is a modification of the procedure described by Ly and a volume of 1ϫ10 6 cells/ml (1ϫ10 5 cells/well) for use in a colleagues (27) for the depletion of adherent cells such as standard T cell proliferation assay. At 24 h, 50 µl aliquots macrophages and DC. Cells were then eluted in 1.5 column were collected from each well and the level of IL-2 produced volumes of RF5 ϩ and then adjusted to a concentration of 2-was determined using the HT2 IL-2-dependent cell line. 4ϫ10 7 cells/ml in a solution containing a 1/4 dilution of antiThy1.2 mAb (prepared by concentrating supernatant from a Cytokine assays culture of the hybridoma 30-H12 using 6000 MW polyethylene Supernatant samples (50 µl) obtained from T cell proliferation glycol). Cells were incubated for 40 min on ice after which assay cultures were added to 4ϫ10 3 HT2 cells in 50 µl of time they were washed once to remove excess antibody.
medium. The cells were incubated overnight at 37°C and, Cells were then resuspended at the same concentration in a after addition of 1µCi/well of [ 3 H]thymidine, for a further 1/6 dilution of Low Tox rabbit complement (Cedarlane, Hornby, 4 h. Cells were then harvested onto glass fiber filters and Ontario, Canada) in RF5 ϩ . Complement-mediated lysis of T incorporation of [ 3 H]thymidine was measured as above. cells was carried out at 37°C for 30 min and the live cells Serum stability assays were then separated from dead cells over Isopaque-Ficoll. Each B cell preparation was analyzed by FACS for purity and
The protocol used was a modification of the method previously described by Hoffman et al. (29) . Briefly, peptide solutions the resulting B cells used in antigen-presentation assays.
were adjusted to~2 mg/ml in saline or PBS and 50 µl added to 200 µl of a 1/10 dilution of either normal mouse serum (NMS) or heat inactivated (56°C for 30 min) FCS. At various time intervals each sample was precipitated by the addition of 40 µl of 15% aqueous trichloroacetic acid and left on ice for 30 min. Samples were then centrifuged for 5 min in a benchtop microfuge to sediment denatured high mol. wt material. Supernatants (150 µl) were then injected onto a Phenomenex C4 reverse-phase HPLC column (10 mmϫ250 mm) installed in a GBC HPLC system (GBC Scientific, Dandenong, Australia). Samples were eluted at a flow rate of 2 ml/ min with a linear gradient (0-60%) of acetonitrile in 0.1% aqueous trifluoroacetic acid. Areas under each peak were then integrated using Winchrom software (GBC Scientific) and in this way the percentage of peptide material remaining at any particular time was calculated.
Results
Branched synthetic peptide constructs are presented more efficiently to CD4 ϩ T cells than linear synthetic peptide constructs when CD8 -DC are used as the APC source CD8 -DC were used to present synthetic peptide constructs of different geometries (Fig. 1) to T cell clones. The relative efficiency of presentation of these synthetic peptide constructs by CD8 -DC was measured by the resulting proliferative response of the clones in cultures containing equimolar amounts of peptide antigen with respect to T cell epitope. The results (Fig. 2) show that there is a marked difference in the ability of CD8 -DC to present synthetic peptide-based (Fig. 2B ) the addition of a B cell determinant in a linear tandem arrangement to the T indicating that perhaps internalization of these antigens by cell epitope (peptide T1-B) did not significantly affect the T specific interaction with the BCR is not a prerequisite for their cell response; however, when assembled in a branched presentation to T cells. In a manner similar to that found when conformation, with either one or two copies of the B cell DC were used as APC, B cells present the branched peptides determinant (T1-K-B or T1-KB-KB), the presentation efficiency T2-K-B and T2-KB-KB to T cell clone 12V1 at~10-fold lower was increased by~10-fold.
antigen concentrations than the corresponding linear peptides T2 and T2-B (Fig. 3A) .
The peptide constructs based on the Presentation of branched synthetic peptide constructs by B
helper determinant T1 did not show such a clear hierarchy of cells is also more efficient and demonstrates differences in stimulation when presented to the corresponding T cell clone presentation patterns compared to DC as an APC source 4.51 (Fig. 3B) , although there was a tendency for the branched Although naive B cells do not contain BCR specific for the B synthetic peptide construct T1-KB-KB to effect proliferation cell determinant and are therefore unable to utilize the BCR at lower doses; the peak of the T cell stimulation to this for antigen uptake, they may still be expected to present less antigen occurred at 1 pmol, a 10-fold lower dose than required complex immunogens such as the linear synthetic peptide to induce peak proliferation with the T1 determinant alone. constructs by virtue of a direct interaction with class II MHC Presentation of peptides by A20 cells mimics the antigenon the B cell surface. We therefore compared the antigen presentation patterns of freshly isolated splenic B cells presentation of branched and linear peptide constructs with naive B cells. The results (Fig. 3) show that B cells are
The data presented in Fig. 2 show that DC, at a concentration of only 50-100 cells/well, are able to induce T cell proliferation. capable of presentation of these more complex antigens for IL-2 content in a bioassay using the IL-2-dependent cell line HT2.
The proliferation of HT2 cells supported by the IL-2 produced by T cell clones 12V1 and 4.51 in response to peptide This raises the possibility that very low numbers of DC in the isolated B cell populations may give a false indication of the constructs presented by the B cell line A20 is shown in Fig.  4(A) . Again greater amounts of IL-2 were produced in cultures antigen presentation capability of B cells. The B cell line A20 was therefore used as a source of APC to support the data containing branched synthetic peptide constructs when compared with linear synthetic peptide constructs. Clone 4.51 obtained with freshly isolated B cells. For these experiments, measurement of direct incorporation of thymidine was not (Fig. 4B) showed little or no difference between the synthetic peptide constructs in the levels of IL-2 elicited when A20 used to measure T cell proliferation as the A20 cells continue to proliferate in culture and doses of γ-irradiation needed to cells were used as APC. These data parallel the results obtained when naive B cells were used as APC, and are in suppress this compromise antigen presentation. Instead, supernatants were taken from each culture well and assessed contrast to those observed with CD8 -DC where the greatest by non-fixed A20 cells (Fig. 4) . In contrast, in Fig. 5 using fixed A20 as APC the difference observed in the hierarchy of presentation of antigens is that the branched synthetic peptide construct T1-KB-KB is less efficient.
Branched synthetic peptide constructs are considerably more stable than linear synthetic peptide constructs containing the same peptide sequences after exposure to mouse serum
There are many factors that can potentially influence the immunogenicity of a peptide construct in vivo amongst which is the relative stability of the immunogens to environmental proteases following injection. We decided, therefore, to investigate the stability of peptides of different geometries in the presence of mouse serum in an attempt to mimic the protease environment to which the immunogens may be exposed when inoculated into mice. This is of particular importance because the longer an antigen can persist in vivo the greater the chances of contacting the relevant immune effector cells. Serum stability was assessed using HPLC analysis to measure the amount of intact peptide present at different times following exposure to a 10% solution of normal mouse serum (Fig. 6A) . The results (Fig. 6B) show that the branched synthetic peptide constructs T1-K-B and T2-K-B were almost twice as resistant to degradation than synthetic peptide constructs containing the same amino acid sequences in a linear conformation. Almost identical results were obtained with branched peptides containing two copies of the B cell determinant (data not shown). In contrast, little or no proteolysis was observed with any of the synthetic peptide body demonstrated by our previous studies (6) is paralleled by their more efficient presentation by both DC and B cells, and also by their resistance to degradation by serum proteases. While the increased susceptibility of linear peptides differences between linear and branched antigens are observed with T cell clone 4.51. These results imply that to breakdown in serum could result in their decreased availability for uptake by APC in vivo leading to decreased antibody contaminating DC are not responsible for the proliferation patterns observed when B cell populations are used to present production downstream, this appears not to be the only factor responsible for the superiority of branched peptides; synthetic peptide constructs to T cell clones.
peptide constructs with branched configurations of T and B Branched and linear synthetic peptide constructs can be cell determinants were also better presented by B cells presented by fixed A20 cells and by CD8α -DC to T cells in vitro in the presence of heat-inactivated FCS, which we show has very little, if any, The data presented in Fig. 5 show that both branched and linear peptides can be presented to some extent by fixed degradative effects on peptide stability. It is likely therefore that the unusual structure of branched immunogens contrib-A20 cells. This is a very inefficient process requiring nanomole rather than picomole doses of antigen to stimulate T cell utes to the increased efficiency of antigen handling by APC and to the enhanced antibody levels observed. responses. For presentation of branched antigens to clone 12V1 by non-fixed cells (Fig. 4A ) the branched synthetic DC were very potent presenters of peptide antigen to secondary T cells with T cell proliferation detected with as peptide construct T2-KB-KB, is the most efficient stimulator of T cells. When fixed cells are used as APC (Fig. 5A ) the few as 50 DC per culture. This contrasts with the B cell system in which 10,000 cells were used as APC to achieve responses branched synthetic peptide construct with only one copy of the B cell epitope is more efficient.
of suitable magnitude. Immature DC are capable of constitutive antigen processing through macropinocytosis of extracelThere is little difference in the presentation of linear and branched synthetic peptide constructs to T cell clone 4.51 lular material, which leads to concentration and deposition of antigen into peptide-loading compartments (30,31). This the macropinocytosis of DC and it is likely that the major pathway for peptide uptake in naive B cells is via interaction processing capability decreases as DC mature and the ability to present antigen increases concurrently with the expression with class II molecules on the cell surface (17) . Perhaps trimming of the more complex structures, to allow their preof adhesion, co-stimulation and MHC class II molecules (32,33). The splenic DC isolated for this work are relatively sentation to T cells, occurs during the recycling of these class II molecules through the early endosomes prior to remature with high levels of class II molecule expression but may nevertheless still be capable of macropinocytosis; DC expression at the cell surface (13) (14) (15) (16) .
The results presented here indicate that both DC and B isolated directly from spleen have been shown in other studies to be able to process complex antigens within the first 24 h cells exhibit preferences for branched immunogens, although some differences in peptide presentation were observed of culture (31). It is likely then that linear and branched peptides used in this study are capable of accessing both between the two APC types, e.g. the clear segregation of branched and linear peptides presented to clone 4.51 by DC macropinocytosis and direct binding to class II molecules on the cell surface for presentation to T cells. Although B cells was not observed with B cells. Similarly, the difference in stimulatory activity of T2-B and T2 observed with DC is not are also capable of pinocytosis, this is far less efficient than evident when these peptides are presented by B cells.
correlation of increased protease stability and presentation efficiency of branched immunogens described here with Because T cell clones were used in this study, the interaction between the class II molecules and the TCR is the same in their enhanced ability to induce antibody responses (6) demonstrates that structural aspects of an immunogen are the two APC types. Any differences observed in DC and B cell presentation of the different forms of antigen must important to consider in the design of synthetic peptidebased vaccines. presumably be due to an intrinsic interaction between the APC and the antigen itself. The peptides generated from branched peptide constructs that are ultimately presented to Acknowledgements T cells may well be different to those derived from linear peptides by virtue of different resistance to proteases or the branched peptides by DC and B cells, is the increased ability of peptides in this form to survive proteolytic environments during macropinocytosis or in the early endosomes of recycReferences ling class II molecules. This hypothesis is made more plausible considering the dramatic difference between the stability of
